GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (STU:2RY0) » Definitions » Pre-Tax Income

China SXT Pharmaceuticals (STU:2RY0) Pre-Tax Income : €-3.02 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is China SXT Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. China SXT Pharmaceuticals's pretax income for the six months ended in Mar. 2024 was €6.07 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-3.02 Mil. China SXT Pharmaceuticals's pretax margin was 667.03%.

During the past 8 years, China SXT Pharmaceuticals's highest Pretax Margin was 32.36%. The lowest was -300.96%. And the median was -111.15%.

China SXT Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for China SXT Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Pre-Tax Income Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Pre-Tax Income
Get a 7-Day Free Trial -9.40 -2.47 -4.91 -5.54 -2.85

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 -1.51 -4.15 -9.09 6.07

Competitive Comparison of China SXT Pharmaceuticals's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China SXT Pharmaceuticals's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's Pre-Tax Income falls into.


China SXT Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

China SXT Pharmaceuticals's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2.314+-0.036+-0.5+0+-0.00099999999999989
=-2.85

China SXT Pharmaceuticals's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=6.287+-0.026+-0.191+0+0
=6.07

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-3.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China SXT Pharmaceuticals  (STU:2RY0) Pre-Tax Income Explanation

China SXT Pharmaceuticals's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=6.07/0.91
=667.03%

During the past 8 years, China SXT Pharmaceuticals's highest Pretax Margin was 32.36%. The lowest was -300.96%. And the median was -111.15%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China SXT Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

China SXT Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (STU:2RY0) » Definitions » Pre-Tax Income
Comparable Companies
CSUI HCANF CPHI MJNE KGKG MNKTQ VFRM STMH KAYS NXEN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
SXTC:USA
Address
No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
Website
http://www.sxtchina.com
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.

China SXT Pharmaceuticals Headlines

No Headlines